Inotiv Inc
NOTV2.040USD
+0.120+6.25%
交易中 （美东）报价延迟15分钟
70.07M总市值
亏损市盈率 TTM
关于 Inotiv Inc 公司
Inotiv, Inc. 是一家合同研究公司，致力于为制药和医疗器械行业提供非临床和分析药物发现和开发服务，并向同一行业以及学术界和政府客户出售一系列研究级动物和饲料。其产品和服务专注于将新药和医疗器械带入发现和临床前开发阶段。该公司通过两个部门运营：发现和安全评估 (DSA) 和研究模型和服务 (RMS)。DSA 部门支持研究人员和临床医生对主要小分子候选药物以及生物治疗和生物医学设备的发现、非临床开发和临床开发需求。RMS 部门提供一系列用于基础研究和药物发现与开发的小型和大型研究模型，以及针对特定疾病和治疗领域的专门模型。
公司简介
公司代码NOTV
公司名称Inotiv Inc
上市日期Nov 25, 1997
CEOMr. Robert W. Leasure, Jr.
员工数量1977
证券类型Ordinary Share
年结日Nov 25
公司地址2701 Kent Ave
城市WEST LAFAYETTE
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编47906-1382
电话13174634527
网址https://www.inotiv.com/
公司代码NOTV
上市日期Nov 25, 1997
CEOMr. Robert W. Leasure, Jr.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
Mr. Brennan Freeman
Mr. Brennan Freeman
Vice President - Finance, Corporate Controller, Principal Accounting Officer
Vice President - Finance, Corporate Controller, Principal Accounting Officer
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Terry Coelho
Ms. Terry Coelho
Independent Director
Independent Director
--
--
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
United States
112.15M
90.21%
Other
7.57M
6.09%
Netherlands
4.60M
3.70%
业务
地区
暂无数据
股东统计
更新时间: 8月1日 周五
更新时间: 8月1日 周五
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
3.76%
Balyasny Asset Management LP
3.70%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Kennedy Capital Management LLC
2.92%
Other
82.34%
持股股东
持股股东
占比
The Vanguard Group, Inc.
3.76%
Balyasny Asset Management LP
3.70%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Kennedy Capital Management LLC
2.92%
Other
82.34%
股东类型
持股股东
占比
Investment Advisor
13.71%
Individual Investor
9.68%
Hedge Fund
6.68%
Corporation
3.67%
Investment Advisor/Hedge Fund
3.46%
Venture Capital
0.08%
Research Firm
0.07%
Private Equity
0.06%
Bank and Trust
0.05%
Other
62.53%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
195
12.97M
37.74%
-3.77M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
2023Q2
284
11.42M
44.51%
-8.98M
2023Q1
283
15.00M
60.03%
-7.75M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
1.29M
3.76%
+204.53K
+18.80%
Mar 31, 2025
Balyasny Asset Management LP
1.27M
3.7%
-33.79K
-2.59%
Mar 31, 2025
Jermyn Street Associates, L.L.C.
1.26M
3.67%
-118.26K
-8.58%
Apr 03, 2024
Leasure (Robert Jr.)
1.24M
3.62%
+429.73K
+52.90%
Mar 14, 2025
Kennedy Capital Management LLC
1.00M
2.92%
-264.30K
-20.84%
Mar 31, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Millennium Management LLC
353.18K
1.03%
+65.28K
+22.67%
Mar 31, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
328.48K
0.96%
+90.63K
+38.10%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Avantis US Small Cap Equity ETF
0%
Avantis US Small Cap Value ETF
0%
Avantis US Equity ETF
0%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
iShares Micro-Cap ETF
占比0.01%
Invesco RAFI US 1500 Small-Mid ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0%
Avantis US Small Cap Value ETF
占比0%
Avantis US Equity ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
DFA Dimensional US Core Equity Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
